The drug manufacturer seeks a federal court ruling to bypass current patent protections for the GLP-1 medication.
Live Poll
Should generic drug manufacturers be granted faster access to markets to lower healthcare costs?
September 24, 2026
Delaware Awarded $23 Million for Rural Health UpgradesHealthcare operators will leverage federal funds to scale technology, mobile units, and workforce capacity.
September 23, 2026
Delaware Court Heard Arguments on Vividion Sale PriceInvestors are challenging the $2 billion acquisition price, claiming intellectual property valuation concerns.
September 21, 2026
Delaware Health Officials Called Spending Trends UnsustainableHealthcare operators should anticipate tighter controls on service pricing as state officials address rising costs.
